A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391

NCT05634447 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemias

Interventions

DRUG: Drug: CKD-391, QD, PO

Sponsor

Chong Kun Dang Pharmaceutical